Kobayashi Pharmaceutical Co., Ltd.
Notice Concerning Dividend of Surplus and Withdrawal of Special Reserves
The year-end dividend for the fiscal year ending December 2025 is 60 yen per share, with a total dividend amount of 4,460 million yen. A transfer of 8,300 million yen from special reserves to retained earnings will be made, effective March 9, 2026.
Key Figures
- Year-End Dividend: 60.00 yen (Fiscal Year Ending December 2025)
- Total Dividend Amount: 4,460 million yen (Fiscal Year Ending December 2025)
- Withdrawal Amount of Special Reserves: 8,300,000,000 yen
AI要約
Overview of Dividend
Kobayashi Pharmaceutical Co., Ltd. has decided on a year-end dividend of 60 yen per share for the fiscal year ending December 31, 2025, resulting in a total dividend amount of 4,460 million yen. This represents an increase from 59 yen per share and 4,385 million yen in the previous fiscal year. The annual dividend amounts to 104 yen when combined with the interim dividend of 44 yen, reflecting the company’s basic policy of maintaining stable dividend payments. The dividend source is retained earnings, and the effective date is March 9, 2026.
Regarding the Withdrawal of Special Reserves
On the same date, a transfer of 8,300,000,000 yen from special reserves to retained earnings will be conducted. This action aims to facilitate flexible and stable dividend payments and is an account transfer within the net assets section of the balance sheet, thus having no impact on net assets or financial performance. The effective date coincides with that of the dividend, March 9, 2026.
Kobayashi Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
